Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA

Robust assay development for SARS-CoV-2 serological testing requires assessment of asymptomatic and non-hospitalised individuals to determine if assays are sensitive to mild antibody responses. Our study evaluated the performance characteristics of two high-throughput SARS-CoV-2 IgG nucleocapsid ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanraj, Dinesh, Bicknell, Kelly, Bhole, Malini, Webber, Caroline, Taylor, Lorna, Whitelegg, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624239/
https://www.ncbi.nlm.nih.gov/pubmed/34835241
http://dx.doi.org/10.3390/vaccines9111310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624239/
https://www.ncbi.nlm.nih.gov/pubmed/34835241
http://dx.doi.org/10.3390/vaccines9111310

Ejemplares similares